Mimosine Dipeptide Enantiomers: Improved Inhibitors Against Melanogenesis And Cyclooxygenase
August 2015
in “
Molecules
”
Studysummary This study found that mimosine dipeptide enantiomers inhibit melanogenesis and cyclooxygenase enzymes in B16F10 melanoma cells, suggesting potential for treating skin hyperpigmentation and inflammation.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study investigated mimosine dipeptides as inhibitors of melanogenesis and cyclooxygenase (COX) enzymes. Mimosine dipeptides, particularly Mi-d-Val, were more effective than mimosine in inhibiting tyrosinase, reducing melanin content, and intracellular tyrosinase activity in B16F10 melanoma cells. They also inhibited COX enzymes, with some dipeptides surpassing the anti-inflammatory drug indomethacin in potency. The research suggested that mimosine dipeptides could be promising for treating hyperpigmentation and inflammation-related disorders, as they effectively inhibited melanogenesis and COX-1/2 with minimal impact on cell growth or viability.
